Newsfeeds - Spark Newswire

2 minute read

News

5 Value Stocks In The Healthcare Sector

Today, 5:18 AM

The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

BXRX

2 minute read

5 Penny Stocks Insiders Are Buying

By Lisa Levin

Today, 5:18 AM

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

CWBR

1 minute read

9 Meters Biopharma, EBRIS Foundation Team Up For Larazotide Trial For COVID-19-Associated Complication In Children

By Vandana Singh

Today, 5:18 AM

9 Meters Biopharma Inc (NASDAQ:NMTR) has collaborated with the European Biomedical Research Institute of Salerno, Italy (EBRIS) to study larazotide for…

NMTR

3 minute read

9 Meters Biopharma, Inc. Announces Collaboration with EBRIS Foundation for Planned Phase 2 Study of Larazotide for the Treatment of Multisystem Inflammatory Syndrome in Children (MIS-C) Resulting from COVID-19

By Benzinga Newsdesk

Today, 5:18 AM

9 Meters Biopharma, Inc. (NASDAQ:NMTR) (the "Company"), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases by studying unique GI biology, today

NMTR

1 minute read

9 Meters Biopharma Q2 EPS $(0.03) Up From $(0.57) YoY

By Steve Krause

Today, 5:18 AM

9 Meters Biopharma (NASDAQ: NMTR) reported quarterly losses of $(0.03) per share.

NMTR

1 minute read

FDA
News

9 Meters Biopharma Sponsored Study Titled ‘VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome.’ Posted To ClinicalTrials.Gov Site

By Benzinga Newsdesk

Today, 5:18 AM

https://clinicaltrials.gov/ct2/show/NCT04988997

NMTR

1 minute read

9 Meters Biopharma Acquires Anti-GIP Monoclonal Antibody For Obesity-Related Disorders

By Vandana Singh

Today, 5:18 AM

9 Meters Biopharma Inc (NASDAQ:NMTR) has acquired global development rights to LOB-0136 (now known as NM-136) that targets glucose-dependent insulinotropic polypeptide…

NMTR

2 minute read

9 Meters Biopharma, Inc. Announces Acquisition Of Humanized Anti-GIP Monoclonal Antibody From Lobesity For $5M Upfront Payment Plus Right To Contingent Payments; $45.5M In Regulatory Milestones And $50M In Sales Milestones

By Bill Haddad

Today, 5:18 AM

- Broadens existing pipeline with a monoclonal antibody against a novel target, glucose-dependent insulinotropic polypeptide (GIP) - - First planned indication is Prader-Willi Syndrome- - IND-enabling studies ongoing

NMTR

5 minute read

55 Biggest Movers From Yesterday

By Lisa Levin

Today, 5:18 AM

Gainers Moving iMage Technologies, Inc. (NYSE: MITQ) shares jumped 700% to settle at $24.00 on Thursday. Moving iMage Technologies priced its initial public offering of 4.2 million common shares at $3 per share.

AIH

2 minute read

Analyzing 9 Meters Biopharma’s Unusual Options Activity

By Benzinga Insights

Today, 5:18 AM

Analyzing 9 Meters Biopharma's Unusual Options Activity Shares of 9 Meters Biopharma (NASDAQ:NMTR) saw some unusual options activity on Thursday. Following the unusual option alert, the stock price moved up to $1.19.

NMTR